News Blog
Veteran Biopharma and CRO Executive Marshall Skelton Joins Catalyst in New Role as SVP of People & Culture
The Triangle Business Journal’s ‘Fast 50’ List Salutes High-Growth, Privately Owned Companies Wilmington, NC, 15 November 2021 – Catalyst Clinical Research, a clinical development and global resourcing organization headquartered in Wilmington, NC, recently announced...
For Second Consecutive Year, Catalyst Clinical Research Named One of Fastest Growing Companies in Triangle
The Triangle Business Journal’s ‘Fast 50’ List Salutes High-Growth, Privately Owned Companies Raleigh, NC, 2 November 2021 – Catalyst Clinical Research has ranked number 40 on the Triangle Business Journal’s (TBJ) 2021 list of fastest 50 growing companies for the...
Catalyst & St. Jude – Working to Treat and Defeat Childhood Cancer
At Catalyst, our company culture is rooted in our people-first foundational belief and a desire to do the right thing. From our philanthropy and volunteering to our sustainability initiatives, we strive to collaborate openly and inclusively for the best impact on...
PJammin’ For Kids With Cancer 2021
According to the American Cancer Society, in 2021, more than 10,000 children under the age of 15 will be diagnosed with some form of cancer. Thanks to the research and development of better therapies, the survival rate has increased to over 80% over the last few...
10 Things a Cancer Survivor Wants You To Know
Catalyst's UK-based Senior Director, Clinical Operations, Nicola Stanislaus, was a young mother who found herself diagnosed with stage II malignant melanoma. Despite disturbing odds and doctors telling her she had a 60% chance of surviving five years, Nicola is here...
Catalyst Named to Inc. 5000 List for Second Year As One of Fastest-Growing Private Companies
Global Clinical Development Organization Ranked No. 934 for 2021 Wilmington, NC, 17 August 2021 – For the second consecutive year, Wilmington-headquartered Catalyst Clinical Research is ranked among the Inc. 5000’s list of fastest-growing private companies in...
